Overview

Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine the efficacy and safety of OPC-1085EL ophthalmic solution in comparison with carteolol long-acting ophthalmic solution in subjects who are insufficiently responsive to carteolol long-acting ophthalmic solution.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Otsuka Pharmaceutical Co., Ltd.
Treatments:
Carteolol
Ophthalmic Solutions
Pharmaceutical Solutions
Criteria
Inclusion Criteria:

- Subjects with diagnosis of bilateral primary open-angle glaucoma or ocular
hypertension

Exclusion Criteria:

- Subjects with ocular conditions as defined by the protocol